Edema surrounding calcified intracranial cysticerci: Clinical manifestations, natural history, and treatment

Pathogens and Global Health

Volumn 106, Issue 5, 2012, Pages 275-279

  Nash, Theodore ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Calcifications; Neurocysticercosis; Perilesional edema; Taenia solium

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYSTICERCUS (CESTODE LARVA); EDEMA; ELECTROENCEPHALOGRAPHY; GRANULOMA; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; SEIZURE; TAENIA SOLIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN EDEMA; CALCINOSIS; CYSTICERCUS; EPILEPSY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEUROCYSTICERCOSIS;

EID: 84874921916     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773212Y.0000000026     Document Type: Article

References (52)

1. Hennenberg R. Die tierischen Parasiten des Zentralnervensystems. In: Lewandowsky M, editor. Handbuch der neurologie. Berlin: Springer; 1912. Vol. 3, pp. 642-683.
2. Escobar A. Pathology of the nervous system. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, editors. Cysticercosis of the central nervous system. Springfield, IL: Charles Thomas; 1983. pp. 27-54.
3. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011;7:584-594.
4. Nash TE, Del Brutto OH, Butman JA, Corona T, DelgadoEscueta A, Duron RM, et al. Calcific neurocysticercosis and epileptogenesis. Neurology. 2004;62:1934-1938.
5. Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, Chavarria A, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology. 2003;22:139-145.
6. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology. 2005;65:229-233.
7. Sanchez AL, Lindback J, Schantz PM, Sone M, Sakai H, Medina MT, et al. A population-based, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol. 1999;93:247-258.
8. Carpio A, Placencia M, Santillan F, Escobar A. A proposal for classification of neurocysticercosis. Can J Neurol Sci. 1994;21:43-47.
9. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med. 1985;145:442-445.
10. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol. 2008;7:1099-1105.
11. Garcia-Noval J, Allan JC, Fletes C, Moreno E, DeMata F, Torres-Alvarez R, et al. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg. 1996;55:282-289.
12. Palacio LG, Jimenez I, Garcia HH, Jiménez ME, Sánchez JL, Noh J, et al. Neurocysticercosis in persons with epilepsy in Medellin, Colombia. The Neuroepidemiological Research Group of Antioquia. Epilepsia. 1998;39:1334-1339.
13. Cruz ME, Preux PM, Debrock C, Cruz I, Schantz PM, Tsang VC, et al. Epidemiology of cerebral cysticercosis in an Andean community in Ecuador. Bull Soc Pathol Exot. 1999;92:38-41.
14. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology. 2006;67:2135-2139.
15. Garcia HH, Herrera G, Gilman RH, Tsang VC, Pilcher JB, Diaz JF, et al. Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board). Am J Trop Med Hyg. 1994;50:152-157.
16. Rawlings D, Ferriero DM, Messing RO. Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis [see comments]. Neurology. 1989;39:739-741.
17. Marquez-Monter H. Cysticercosis. In: Marcial-Rojas RA, editor. Pathology of protozoal and helminthic diseases. Baltimore, MD: The Williams and Wilkens Company; 1971. pp. 592-617.
18. Raliela-Cervantes MTR, Rivas-Hernandez A, Rodriguez-Ibarra J, Castillo-Medina S, Cancino FDM. Anatomopathological aspects of human brain cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltran F, editors. Cysticercosis: present state of knowledge and perspectives. New York: Academic Press; 1982. pp. 179-200.
19. Chacko G, Rajshekhar V, Chandy MJ, Chandi SM. The calcified intracorporeal vacuole: an aid to the pathological diagnosis of solitary cerebral cysticercus granulomas. J Neurol Neurosurg Psychiatry. 2000;69:525-527.
20. Robles C, Sedano AM, Vargastentori N, Galindovirgen S. Long-term results of praziquantel therapy in neurocysticercosis. J Neurosurg. 1987;66:359-363.
21. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350:249-258.
22. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology. 2004;62:2236-2240.
23. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology. 1994;44:1706-1709.
24. Pradhan S, Kathuria MK, Gupta RK. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol. 2000;48:181-187.
25. Gupta RK, Kumar R, Chawla S, Pradhan S. Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia. 2002;43:1502-1502.
26. Garcia-Noval J, Moreno E, de Mata F, Soto de Alfaro H, Fletes C, Craig PS, et al. An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol. 2001;95:167-175.
27. Cruz ME, Schantz PM, Cruz I, Espinosa P, Preux PM, Cruz A, et al. Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol. 1999;28:799-803.
28. Bordignon KC, Arruda WO. CT scan findings in mild head trauma: a series of 2,000 patients. Arq Neuropsiquiatr. 2002;60:204-210.
29. Monteiro L, Nunes B, Mendonca D, Lopes J. Spectrum of epilepsy in neurocysticercosis - a long-term follow-up of 143 patients. Acta Neurol Scand. 1995;92:33-40.
30. Murthy JM, Reddy VS. Clinical characteristics, seizure spread patterns and prognosis of seizures associated with a single small cerebral calcific CT lesion. Seizure. 1998;7:153-157.
31. Cukiert A, Puglia P, Scapolan HB, Vilela MM, Marino Junior R. Congruence of the topography of intracranial calcifications and epileptic foci. Arq Neuropsiquiatr. 1994;52:289-294.
32. Singh G, Sachdev MS, Tirath A, Gupta AK, Avasthi G. Focal cortical-subcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent. Epilepsia. 2000;41:718-726.
33. Agarwal A, Raghav S, Husain M, Kumar R, Gupta RK. Epilepsy with focal cerebral calcification: role of magnetization transfer MR imaging. Neurol India. 2004;52:197-199.
34. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992;42:389-392.
35. White AC, Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis. 1997;24:101-113.
36. Garg RK, Karak B, Mohan Kar A. Neuroimaging abnormalities in Indian patients with uncontrolled partial seizures. Seizure. 1998;:497-500.
37. Sheth TN, Lee C, Kucharczyk W, Keystone J. Reactivation of neurocysticercosis: case report. Am J Trop Med Hyg. 1999;60:664-667.
38. Nash TE, Patronas NJ. Edema associated with calcified lesions in neurocysticercosis. Neurology. 1999;53:777-781.
39. Park SY, Barkovich AJ, Weintraub PS. Clinical implications of calcified lesions of neurocysticercosis. Pediatr Infect Dis J. 2000;19:581-583.
40. Antoniuk SA, Bruck I, Dos Santos LH, Pintarelli VL, Navolar FB, Brackmann PC Jr, et al. Seizures associated with calcifications and edema in neurocysticercosis. Pediatr Neurol. 2001;25:309-311.
41. Nash TE, Pretell J, Garcia HH. Calcified cysticerci provoke perilesional edema and seizures. Clin Infect Dis. 2001;33:1649-1653.
42. Poeschl P, Janzen A, Schuierer G, Winkler J, Bogdahn U, Steinbrecher A. Calcified neurocysticercosis lesions trigger symptomatic inflammation during antiparasitic therapy. Am J Neuroradiol. 2006;27:653-655.
43. Ooi WW, Wijemanne S, Thomas CB, Quezado M, Brown CR, Nash TE. Short report: a calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg. 2011;85:460-463.
44. Medina MT, Dubon-Murcia SA, Aquilar-Estrada RL, ChavesSell F, Bu J. Neurocysticercosis and epilepsy. Epilepsies. 2010;22:126-133.
45. Milligan TA, Zamani A, Bromfield E. Frequency and patterns of MRI abnormalities due to status epilepticus. Seizure. 2009;18:104-108.
46. Raghavendra S, Ashalatha R, Krishnamoorthy T, Kesavadas C, Thomas SV, Radhakrishnan K. Reversible periictal MRI abnormalities: clinical correlates and long-term outcome in 12 patients. Epilepsy Res. 2007;73:129-136.
47. Cole AJ. Status epilepticus and periictal imaging. Epilepsia. 2004;45 Suppl 4:72-77.
48. Sheth TN, Pillon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol. 1998;19:79-82.
49. Rabiela MT, Rivas A, Flisser A. Morphological types of Taenia solium cysticerci. Parasitol Today. 1989;5:357-359.
50. Singhi PD, Dinakaran J, Khandelwal N, Singhi SC. One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. J Trop Pediatr. 2003;49:274-278.
51. Nash TE, Mahanty S, Garcia HH, Cysticercosis Group in Peru. Corticosteroid use in neurocysticercosis. Expert Rev Neurother. 2011;11:1175-1183.
52. Mitre E, Talaat KR, Sperling MR, Nash TE. Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin Infect Dis. 2007;44:549-553.